Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials

BACKGROUND: Dual antiplatelet therapy (DAPT) has important implications for clinical outcomes in coronary disease. However, the optimal DAPT duration remains uncertain. METHODS AND RESULTS: We searched four major databases for randomised controlled trials comparing long-term (≥12 months) with short-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bularga, Anda, Meah, Mohammed N, Doudesis, Dimitrios, Shah, Anoop S V, Mills, Nicholas L, Newby, David E, Lee, Kuan Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330558/
https://www.ncbi.nlm.nih.gov/pubmed/34341097
http://dx.doi.org/10.1136/openhrt-2021-001707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330558/
https://www.ncbi.nlm.nih.gov/pubmed/34341097
http://dx.doi.org/10.1136/openhrt-2021-001707

Ejemplares similares